Update;Slides Telaprevir/Boceprevir-Efficacy and Safety

Posted on May 05, 2011

Drugs Advisory Committee Updates

Telaprevir

FDA

Overview Of Clinical program / efficacy / safety

• FDA Presentation for the April 28, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 321KB)

Rash Severity Grading

• Vertex Backup Presentation for the April 28, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 143KB)⁵  (PDF - 142KB)

Telaprevir/Vertex Presentation

• Vertex Main Presentation for the April 28, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 604KB)⁶  (PDF - 604KB)

Boceprevir

FDA
,

FDA Presentation for the April 27, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 1.03MB)^1
,

Merck & Co., Inc

Merck Main Presentation for the April 27, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 346KB)^2
,

Merck Backup Presentation for the April 27, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 62KB)³

,

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

View All Updates